Takbo Group Holdings Limited (8436.HK)
HKD 0.18
(-1.1%)
HKD 0.18
(-1.1%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 42.84 Million HKD | 10.74% |
| 2022 | 38.69 Million HKD | -1.64% |
| 2021 | 39.33 Million HKD | -52.26% |
| 2020 | 82.39 Million HKD | 54.57% |
| 2019 | 53.3 Million HKD | 176.76% |
| 2018 | 19.26 Million HKD | 25.57% |
| 2017 | 15.33 Million HKD | -76.99% |
| 2016 | 66.66 Million HKD | 13.8% |
| 2015 | 58.57 Million HKD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 38.36 Million HKD | -10.47% |
| 2024 Q2 | 38.36 Million HKD | 0.0% |
| 2023 Q3 | - HKD | -100.0% |
| 2023 Q1 | - HKD | -100.0% |
| 2023 FY | 42.84 Million HKD | 10.74% |
| 2023 Q2 | 49.59 Million HKD | 0.0% |
| 2023 Q4 | 42.84 Million HKD | 0.0% |
| 2022 Q2 | 42.69 Million HKD | 0.0% |
| 2022 Q1 | - HKD | -100.0% |
| 2022 FY | 38.69 Million HKD | -1.64% |
| 2022 Q4 | 38.69 Million HKD | 0.0% |
| 2022 Q3 | - HKD | -100.0% |
| 2021 Q2 | 54.5 Million HKD | 0.0% |
| 2021 Q1 | - HKD | -100.0% |
| 2021 FY | 39.33 Million HKD | -52.26% |
| 2021 Q4 | 39.33 Million HKD | 0.0% |
| 2020 FY | 82.39 Million HKD | 54.57% |
| 2020 Q4 | 82.39 Million HKD | 0.0% |
| 2020 Q1 | - HKD | -100.0% |
| 2020 Q2 | 51.67 Million HKD | 0.0% |
| 2019 Q2 | 60.08 Million HKD | 0.0% |
| 2019 Q1 | - HKD | -100.0% |
| 2019 Q4 | 53.3 Million HKD | 0.0% |
| 2019 FY | 53.3 Million HKD | 176.76% |
| 2018 Q4 | 19.26 Million HKD | 0.0% |
| 2018 FY | 19.26 Million HKD | 25.57% |
| 2018 Q2 | 19.55 Million HKD | 0.0% |
| 2018 Q1 | - HKD | -100.0% |
| 2017 Q1 | 16.98 Million HKD | -74.52% |
| 2017 Q4 | 15.33 Million HKD | 0.0% |
| 2017 FY | 15.33 Million HKD | -76.99% |
| 2016 Q4 | 66.66 Million HKD | 0.0% |
| 2016 FY | 66.66 Million HKD | 13.8% |
| 2015 FY | 58.57 Million HKD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 308.05 Million HKD | 86.091% |
| Innovative Pharmaceutical Biotech Limited | 1.06 Billion HKD | 95.971% |
| China Overseas Nuoxin International Holdings Limited | 109.1 Million HKD | 60.725% |
| Prosperous Future Holdings Limited | 177.1 Million HKD | 75.806% |
| Huasheng International Holding Limited | 675.58 Million HKD | 93.657% |
| Fourace Industries Group Holdings Limited | 61.8 Million HKD | 30.671% |
| Evergreen Products Group Limited | 786.46 Million HKD | 94.552% |
| EC Healthcare | 2.97 Billion HKD | 98.557% |
| Ming Fai International Holdings Limited | 772.01 Million HKD | 94.45% |
| Blue Moon Group Holdings Limited | 1.61 Billion HKD | 97.351% |
| SuperRobotics Holdings Limited | 172.27 Million HKD | 75.127% |
| Hyfusin Group Holdings Limited | 181.34 Million HKD | 76.372% |